GSK Acquires GlycoVaxyn for $212 Million

16.02.2015 - GlaxoSmithKline (GSK), the UK's largest drugmaker, has acquired Swiss-based GlycoVaxyn, a privately held specialist vaccine biopharmaceutical producer, from Edmond de Rothschild...